We are delighted to announce that Dr. Jan-Uwe Claas is joining PROVIREX from March 1st onwards our new Chief Executive Officer and as Partner of PROVIREX. With over 25 years of comprehensive experience in the biotech and pharmaceutical industries, Dr. Claas brings a wealth of expertise spanning from pre-clinical research through to international marketing and general management.
Throughout his career, Dr. Claas has been instrumental in the commercial development and successful launch of innovations on both national and international levels. He has led complex organizations with proven record of effective leadership and clear strategic direction. His extensive international experience includes 10 years in European Managing Director roles and longstanding collaborations with global industry leaders.
In addition to his executive accomplishments, Dr. Claas has also supported start-up businesses through mentoring and coaching, further highlighting his commitment to innovation and growth within the sector.
Dr. Claas’s diverse background, strategic insight, and proven track record will drive PROVIREX forward as we continue to expand our breakthrough technology in gene editing for the benefit of people living with HIV. Please join us in warmly welcoming Dr. Jan-Uwe Claas to the PROVIREX team.
